NCT01482754
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- National University Hospital Singapore
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,988 public trials
1,836 recruiting studies
Lymphatic Diseases trial results
NCT02005653
- Conditions
- Elephantiasis, Filarial, Filarial; Infestation, Filariasis, +11 more
- Locations
-
- Vector Control Research Centre Puducherry, India
NCT00911066
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +15 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, Illinois, United States
- Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00185445
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Bologna, BO, Italy
- Cesena, FC, Italy
- Forlì, FC, Italy
- Genova, GE, Italy
NCT00688883
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Fukuoka, Japan
Completed
Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
NCT00311129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Isehara-shi, Kanagawa, Japan
NCT00003421
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
- St. James's Hospital Leeds, England, United Kingdom
- Weston Park Hospital Sheffield, England, United Kingdom
NCT00220311
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
Not specified
NCT00344825
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Many Locations, Italy
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States